Dear Alumni,
It is with immense humility, gratitude, and honor that I accept the role as the current President of the Stanford Medicine Alumni Association (SMAA). I am truly excited to embark on this journey with all of you.
The strategic mission of SMAA is to Reach, Inspire, Serve, and Engage (RISE) Stanford Medicine alumni from the Stanford School of Medicine and Stanford Health Care. We are committed to building a vibrant and inclusive community, providing enriching educational programs, strengthening alumni connections, supporting excellence and diversity, and encouraging robust volunteerism across our network.
Our alumni association is unique. Unlike many other medical alumni programs focused solely on MD graduates, we proudly serve a diverse audience of degreed alumni in medicine and the biosciences, residents, fellows, postdocs, and other alumni constituencies. This incredible breadth is our strength, and it is what makes our community so special and gives our alumni network its strength and vibrancy. While our professional journeys are diverse, we share a common academic heritage and a deep connection to Stanford Medicine.
Whether you are looking to give back through mentorship, volunteerism, or simply connecting with former colleagues, there are countless ways to engage and make an impact. I invite you to visit our website to explore the many opportunities for involvement and to stay informed about upcoming events, initiatives, and ways you can contribute to the ongoing success of our community.
We believe in the power of connection. We are eager to hear from you – your insights, ideas, and experiences are invaluable. Your involvement can help continue the spirit of innovation that defines Stanford Medicine and shape the training of the next generation of physicians and scientists. Together, let's make this an exceptional year for SMAA!
With anticipation,
Ethan A. Nicholls, M.D.
President
Stanford Medicine Alumni Association
Board Officers
Ethan Nicholls
MD ’88
PRESIDENT
Dr. Ethan A. Nicholls received his A.B. from Harvard University, his M.D. from Stanford University and completed his Anesthesia residency and fellowship in Pain Management at the University of California, San Francisco (UCSF).
He joined the Palo Alto Foundation Medical Group in March 2015 where he currently serves as Chair of the Department of Anesthesia, Alameda Division. Previously, he was a senior partner and served as President of Northern California Anesthesia Associates (2004-2015). After completing his residency and fellowship training, Dr. Nicholls held the position of Assistant Professor of Anesthesiology and Pain Management at the University of California, San Francisco before leaving for private practice and working at El Camino Hospital, and later Washington Hospital.
In addition to his clinical practice, Dr. Nicholls has served in numerous other roles. Most recently on the Board of Trustees, Castilleja School in Palo Alto (2011-2017). He served as a Delegate, District 4, California Society of Anesthesiology (2001-2007) and previously held multiple staff and committee positions at El Camino Hospital including Chief, Department of Anesthesiology.
Dr. Nicholls has two daughters, is a Stanford Women’s Basketball season ticket holder and enjoys traveling and attending the theatre and SF Opera.
Shelley Force Aldred
PhD ’05
PRESIDENT-ELECT
Shelley Force Aldred is CEO and Co-founder of Rondo Therapeutics, a preclinical stage biopharmaceutical company developing bispecific therapeutic antibodies that enable controlled activation of the immune system to fight cancer. Previously, Dr. Force Aldred served as VP for Preclinical Development at TeneoBio, a highly successful multispecific therapeutic antibody company. She was part of the formation of TeneoBio and led the preclinical efforts creating a CD3xBCMA bispecific antibody, from product concept to IND-ready package. Dr. Force Aldred was formerly director of worldwide R&D for Active Motif following the acquisition of SwitchGear Genomics in 2013. In 2006, she co-founded SwitchGear Genomics, a venture-backed functional genomics platform company, and she served as its COO and Board Member. Prior to founding SwitchGear Genomics, Dr. Force Aldred was a Scientific Director on Stanford’s ENCODE Project and received her Ph.D. from Stanford University.
Deval Lashkari
PHD ’96
PAST PRESIDENT
Dr. Lashkari has worked in the life sciences area developing and commercializing novel technologies. During his time as a graduate student, Dr. Lashkari worked at the Stanford Genome Technology Center on new technologies used in the human genome project. He was also President of BioMASS and was involved with summer research programs for minority undergraduate students. After completing his PhD in Genetics, he became a founding research director for a genomics tools company. He gained corporate and business development experience through senior management positions in a number of life science businesses. Dr. Lashkari is a co-founder and Senior Partner at Telegraph Hill Partners, a San Francisco based life sciences and healthcare venture capital firm and works closely with innovative healthcare companies.
Jessica Ngo
MD ’05
SECRETARY
Jessica Ngo is board certified in Emergency Medicine, fellowship trained in Emergency Medical Services and Disaster Medicine, and certified in Wound Care and Hyperbaric Medicine. She completed her undergraduate degree from University of Pennsylvania, then transplanted to the west coast where she completed medical school, residency and fellowship at Stanford University. She served as an attending physician and Assistant Professor of Emergency Medicine at Stanford University for 12 years.
Dr. Ngo has a passion for disaster response as well as education. She served on the Stanford Hospital Disaster Planning Committee Board, then co-founded Stanford’s first disaster deployment team named SEMPER, Stanford Emergency Medicine Program for Emergency Response. She has directed numerous disaster responses around the world, starting with the 2010 Haiti earthquake. She developed the drive-through medicine model, which has since been published and adapted around the world for Covid-19 testing and vaccinations. For over a decade she was very involved in Stanford medical student education, as Director of the Emergency Medicine Clerkship, Medical School Procedure Course and Stanford EMT Course. Dr. Ngo transitioned to the Palo Alto Veteran’s Affair hospital Emergency Department as their disaster expert.
I-Han Liang
BA ’97
EXECUTIVE DIRECTOR, ALUMNI RELATIONS
Board Members
Jane Binger
BS ’73, MA '80, ED '82
Dr. Binger has dedicated her career to the intersection of education, healthcare, and breaking barriers so college students and healthcare professionals of all backgrounds can reach their professional dreams.
Presently, Jane is Co-Founder and Chief Learning Officer of DeepTok, a Foundation for California Community Colleges non-profit; Senior Advisor, Center of Excellence in Diversity in Medical Education, Stanford Medicine; Diplomat, University of California Merced Foundation where she co-sponsors the Grad Slam Research Presentation Competition; and an Executive Board Member, California Medicine Coalition. Previously, she was a Senior Research Officer, Sutter Health, where she led teams that developed the first system-wide strategy for research, personalized medicine, and graduate medical education. She was Executive Director, Physician Leadership Education, Lucile Packard Children’s Hospital Stanford for nine years.
Dr. Binger enjoys volunteering for the National Hispanic Medical Association Annual Conference Committee, Napa Valley College MESA/STEM Center Advisory Board, and Stanford University as an undergraduate admissions alumni interviewer. She earned her BS, and MA and Doctorate in Education from Stanford University, and MS from UCSF. On weekends, you will find Jane hanging out with her husband (Bob Bernstein, AB ’77, AM ’77, MD ’80) and family, and fishing in the High Sierra.
Mark Ping Chao
MD '08, PhD '11, Fellow '14, Resident '16
Dr. Mark Chao is a physician-scientist, hematologist and biotechnology entrepreneur with a focus in oncology and regenerative medicine research. He is currently co-founder and CEO of TenSixteen Bio, a precision therapeutics platform company. Mark previously served as Vice President of Oncology Clinical Research at Gilead Sciences. Prior to that, Mark was co-founder and Senior Vice President of Clinical Development at Forty Seven, Inc., an immuno-oncology company developing first-in-class macrophage-directed therapeutics which was acquired by Gilead Sciences for $4.9B in 2020. As one of the scientific pioneers discovering CD47 as a target in cancer, Mark helped lead research from lab discovery through late-stage clinical development. Mark was named one of the 20 under Forty in biopharma leaders by Endpoints News. He has broad interests in translational research, clinical development and biotechnology company formation.
He received his medical degree, PhD in cancer biology and internal medicine and hematology training at Stanford University. He serves on the board of directors for Hepatx Corporation, the Northern California Chapter of the Leukemia Lymphoma Society and on the scientific advisory boards of TigaTx and IconOVir Bio. He and his wife Alice (BA ’99, PhD ’09) are proud Stanford alumni and have three young children.
Peter Yee-Chew Chiu
MD ’83
Dr. Peter Y. Chiu is an Emeritus Adjunct Clinical Professor of Medicine at Stanford University and has been very active in the Stanford MD Admissions Program and the First-Generation Mentorship Program of Stanford Medicine. Since 2013 he has been on the Bay Area Air Quality Management District (BAAQMD) Hearing Board that serves to adjudicate regulatory compliance issues that may arise between the BAAQMD and local industries. Previously, he practiced as an Occupational Medicine Department and Emergency Department physician at Kaiser Milpitas/Santa Clara from 1990 to 2011 and as a Family Medicine physician in San Jose from 1986 to 1990. Additionally, he was appointed by Governor Brown to serve on the California State Board of Behavioral Sciences from 2013-2019 and by President Clinton to serve on the US Presidential/Congressional Environmental Risk Assessment and Risk Management Commission from 1994 to 1997. Prior to his career in medicine, Dr. Chiu was a principal environmental engineer for the Association of Bay Area Governments from 1976 to 1979. He received his MD degree from Stanford University and his BS, MPH and DrPH degrees from the University of California, Berkeley.
Chana Davis
PhD ’06
Chana Palmer Davis is a geneticist who is passionate about helping the public use science to make informed, healthy choices. Her areas of expertise include precision medicine, companion diagnostics, cancer early detection, the human microbiome, and plant-based nutrition. Chana completed her PhD in genetics at Stanford in the lab of Dr. Patrick Brown before spending a decade in biomedical research at the Canary Foundation, Genentech/Roche, and Genome British Columbia. In 2018, Chana shifted her focus to science communication, and founded Fueled by Science. Through her podcast, articles, and posts, she shares digestible, science-based resources, fights misinformation, and teaches others to think like a scientist. Chana lives in beautiful Vancouver, Canada with her husband and three children.
George Demetri
MD ’83
Dr. Demetri is the Quick Family Chair in Medical Oncology at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School, where he co-directs the Ludwig Center at Harvard with Joan Brugge, PhD. His career as a physician-scientist has focused on developing therapies targeting specific oncogenic mechanisms to treat molecularly-defined subsets of sarcomas and other cancers. He led the development of imatinib as the first effective therapy for gastrointestinal stromal tumor (GIST) as a paradigm of a mutation-driven solid tumor. Subsequently, he led the development of the next two FDA-approved drugs for GIST (sunitinib and regorafenib) after resistance to imatinib appeared. On the basis of this body of work, Dr. Demetri was awarded the 2020 David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO). His research efforts have subsequently contributed to U.S. FDA approval of multiple other therapies to treat GIST (e.g. avapritinib), other sarcomas (e.g. trabectedin, pazopanib and eribulin), and other malignancies. Working at the interface of academic discovery and biopharma development, Dr. Demetri serves on several scientific advisory boards and recently co-founded IDRx, a clinical stage biotech company, to develop next-generation therapies for GIST.
Maribel Hernández
MD ’85
Dr. Maribel Hernández received her undergraduate degree at Yale University and Medical Degree at Stanford University School of Medicine in 1985. In May 2025 she completed the 5 years appointment as member of the Board of Directors of Stanford Alumni Association. She did her internal medicine residency in the Harvard Hospital System in Boston and her cardiology and cardiac electrophysiology fellowships at the Hospital of the Medical College of Pennsylvania and the Lankenau Medical Center. Dr. Hernández is Board Certified by the American Board of Cardiovascular Disease and Clinical Cardiac Electrophysiology. She is also the Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University. She is a Fellow of the American College of Cardiology and Fellow of The College of Physicians of Philadelphia. Serving as a clinical cardiac electrophysiologist on the medical staff of Main Line Health System for over 25 years, Dr. Hernández specializes in managing patients with heart rhythm disorders and has played an active role in cardiac arrhythmia clinical research including drug, device and catheter ablation therapies. She is co-founder and serves as the Medical Director of Lankenau Heart Institute’s Women’s Heart Initiative, supporting awareness, education, and prevention of heart disease in women within the community and in Main Line Health System.
In June 2024 she received the Wenger Awards for Excellence in Clinical Practice Women Heart National Organization in Washington, DC. She was the recipient of the AHA Philadelphia Chapter’s 2014 Por Tu Corazón Ambassador Award for her volunteer work educating Latina women and the Hispanic community. Dr. Hernández is a member of professional and nonprofit community organizations. They include board member of Congreso de Latinos Unidos in Philadelphia, member of the Women's Nonprofit Leadership Initiative, and Stanford Alumni Association Philadelphia Chapter. She is married to Richard L. Davis, PHD ‘86 and has one daughter Samantha I Davis ‘19, both physicists.
Linus Ho
MD ’91, PhD ’91
Dr. Linus Ho is a medical oncologist, researcher, and entrepreneur based in Houston, Texas. He is the chief oncology officer for Aviceda Therapeutics, a clinical-stage pharmaceutical company developing novel immunology-based therapies; chief medical officer for Empiri, a biotech company developing an automated in vitro assay to predict patient responses to cancer drugs; and chief scientific officer for Hub Biosciences, a start-up pharmaceutical company developing enhancer RNA-based therapeutics.
Dr. Ho graduated with highest honors from the University of Texas at Austin with a B.S. in Chemistry and a B.A. in Zoology. He earned his M.D. and Ph.D. (Cancer Biology) degrees from Stanford before completing a residency in internal medicine at Brigham and Women’s Hospital and a fellowship in hematology/oncology at the combined BWH/Dana-Farber Cancer Institute program. Concurrently, he completed a postdoctoral fellowship in the laboratory of Kevin Struhl at Harvard Medical School. Dr. Ho began his academic career at the DFCI before moving to M. D. Anderson Cancer Center, where his research interests spanned molecular oncology, translational medicine, and clinical care of gastrointestinal malignancies. He was a principal investigator or co-investigator on numerous clinical trials and has published extensively in the scientific literature. Dr. Ho is board-certified in both internal medicine and medical oncology.
Linus is currently pursuing his executive MBA at the Jones School of Business at Rice University. He enjoys traveling with his wife, Rosa (MD ’93), as well as reading, cycling, and playing the piano.
Jak Knowles
MD ’09
Dr. Jak Knowles, MD is a seasoned veteran of the life science industry, where he has worked as an entrepreneur, operator, and investor. Jak most recently served as Co-founder, President & CEO of Affini-T Therapeutics, a clinical stage immune oncology company developing T-cell therapies against oncogene driver mutations. Prior to launching Affini-T, Jak served as Co-founder and Chief Business Officer for Metagenomi, a next-generation gene editing company based in Emeryville, CA. As an investor, Jak served as Head of Health Investment team at Leaps by Bayer, a corporate venture capital fund and started his career in biotech VC with MPM Capital. Prior to joining Bayer, Jak served as CEO of CytoSen Therapeutics, developing Natural Killer immune cell therapies for hematologic malignancies. In 2016, Jak co-founded and launched Exonics Therapeutics (acquired by Vertex), an in vivo CRISPR gene-editing company working on Duchenne Muscular Dystrophy, serving as President and interim-CEO. Jak has served on the Board of Directors for Affini-T, Century Therapeutics, Exonics, Metagenomi Technologies, and Pyxis Oncology.
Jak graduated from Stanford University School of Medicine in 2008 with a focus on biomedical research and has undergraduate degree in Biology from Binghamton University.
Elizabeth Joyce
Post Doc ’05 and '07
Dr. Elizabeth A. Joyce is an Adjunct Professor in the Department of Microbiology and Immunology at the University of California at San Francisco School of Medicine and the director of the Microbiology Teaching Laboratory. She holds a joint appointment in the Department of Cell and Tissue Biology in the UCSF School of Dentistry. Dr. Joyce earned her BS in Microbiology from Cornell University and her PhD in Molecular Microbiology from Tufts Graduate School of Biomedical Sciences. She did her Post doctoral training in bacterial pathogenesis in the Department of Microbiology and Immunology at Stanford University School of Medicine. She serves on the Integrated National Board Dental Examination Test Construction Team and has mentored over 20 preprofessional students.
At UCSF, she teaches microbiology and immunology in the Schools of Medicine and Pharmacy and co-directs the foundational sciences stream in the School of Dentistry. A recipient of multiple teaching awards—including the ADEA/John Greene Society Distinguished Faculty Award, the Haile T. Debas Excellence in Teaching Award, and the 2025 Academic Senate Distinction in Teaching Award—she is passionate about helping students apply foundational science concepts to clinical contexts and is known for her commitment to learner-centered, clinically integrated instruction.
Sofia Guajardo Beskid
PhD Candidate, Student Representative
Sofia is a Ph.D. candidate in the Stanford Biology program. In her thesis work, she investigates the evolutionary forces driving protein sequences. She is also an awardee of the NSF Graduate Research Fellowship Program (GRFP). Before arriving at Stanford, Sofia earned a B.S. in Environmental Science from the University of Texas at Austin. After her Ph.D., she is interested in joining an early-stage startup. Outside the lab, Sofia serves as a Stanford Community Associate and can often be found playing golf or practicing yoga.
Nirav Kamdar
MD ’10
Nirav Kamdar is a physician executive with over 10 years of clinical, administrative, business administration, research, boardroom, and advisory board experience within community, and academic healthcare organizations. He is a native Californian, growing up in Los Angeles, and cherished his years at Stanford Medical School for its training, the research he conducted, and the flexibility that the medical school offered to explore non-traditional contributions to medicine and healthcare. After medical school, Nirav trained in Boston to become an anesthesiologist, and thereafter took a faculty position at UCLA practicing anesthesia, doing research in perioperative telemedicine applications and conducting administrative work in quality improvement and patient safety. Simultaneously, he served on the medical advisory board of seed and venture funded medical device startups in hospital quality improvement and digital health. Most recently, he pivoted his career to an executive administration role at a large, 619-bed, hospital affiliated with the Cedars- Sinai Health System. As an active member in the Los Angeles community, he serves as a board member of a classical music society, Salastina, co-founded by another Stanford alumnus that builds community amongst both supporters and patrons of the performing arts, and works with UCLA to deliver music to patients in the intensive care unit through Salastina’s Vital Sounds program.
Bernd Kutzscher
’71, MD ’80
Dr. Kutzscher is a 34-year boarded private practice ophthalmologist, and now Chief of Comprehensive Ophthalmology, California Pacific Medical Center, San Francisco as well as Associate Clinical Professor, Dept of Ophthalmology at UCSF. For three decades he has served as an international & local volunteer eye surgeon for those in need with groups such as Hospital de la Familia, San Marcos, Guatemala; Orbis International (Flying Hospital), Surgical Volunteer, Vietnam; Clinic by the Bay (free San Francisco clinic) and Rotacare Free Clinic, Seton Medical Center (Co-Founder). He has served on the American Academy of Ophthalmology, Public Information Committee, and has been an SUSOM Ophthalmology instructor as well as serving on the Stanford Medical Staff in Ophthalmology. He is an American Academy of Ophthalmology, Fellow, 1990 and was American Board of Ophthalmology, Board Certified, in 1989. He is married to Marilyn Kutzscher, MD and they have three children who have pursued careers in medicine. He loves whitewater rafting, downhill and cross-country skiing, bicycling, and the San Francisco ballet and symphony.
Kimberly Lee
’97, MD ’03
Dr. Lee is an otolaryngologist/facial plastic and reconstructive surgeon in private practice in Beverly Hills, CA. She is an Assistant Clinical Professor in Head and Neck Surgery at UCLA and Attending Physician at Cedars-Sinai Medical Center. She graduated from Stanford University with Honors in Biological Sciences and Honors in Humanities, as well as Phi Beta Kappa and Academic Distinction, and was awarded the prestigious Dinkelspiel Award for her contributions as a campus leader while at Stanford. Dr. Lee completed her MD degree at Stanford followed by residency in Otolaryngology/ Head and Neck surgery at UCLA, where she was Chief Resident. Dr. Lee completed her fellowship training in Facial Plastic and Reconstructive Surgery. Dr. Lee has over a decade of hands-on clinical experience including establishing and managing a medical practice, training other plastic surgeons and injectors as a national trainer on behalf of pharmaceutical companies Galderma and Allergan, serving as a clinical advisor for medical device companies, and serving as a medical expert for numerous media outlets. She is a Committee Member for both the Women in Facial Plastic Surgery and Face to Face, a pro bono organization through the American Academy of Facial Plastic and Reconstructive Surgery dedicated to assisting victims of domestic violence. In addition to her professional accomplishments, she is an avid golfer who enjoys traveling, the fine arts, and spending time with her twin sons.
Alicia Levey
PhD ’08
Dr. Alicia Levey currently serves as President and COO at Pionyr Immunotherapeutics leading business development and operations, portfolio strategy, and program management in addition to managing intellectual property and legal functions. Prior to Pionyr, Dr. Levey served as the CBO of Tempest Therapeutics and was a key contributor to establishing the company outside of Inception Sciences and raising $70M in venture funding. Leading up to the spin-out of Tempest, she was VP of Business Development at Inception Sciences, a small molecule drug discovery company formed in collaboration with Versant Ventures, a global venture capital firm focused primarily on early stage investing and biotechnology company creation. Dr. Levey served as a member of the Versant Ventures Investment Team for over 8 years, most recently as an Operating Principal. While at Versant, she was a key contributor to multiple Series A investments as well as business development efforts for portfolio companies. Dr. Levey worked as a Consultant, and later a Project Leader in The Boston Consulting Group. While at Stanford, she focused on the development of novel protease inhibitors and activity based probes for diagnostic imaging applications. Dr. Levey earned a Ph.D. in Cancer Biology from the Stanford University School of Medicine.
Aditi Mallick
MD ’13
Aditi Mallick, M.D. is the Chief Medical Officer for the Center for Medicaid and CHIP Services, where she leads the Center’s clinical strategy and cross-center work on health equity, social determinants of health, and innovation in whole-person care among other areas. Before joining CMCS, Dr. Mallick led the COVID-19 Response Command Center for the North Carolina Department of Health and Human Services (NCDHHS) where she oversaw efforts around vaccination, testing, case investigation, and contact tracing statewide. A core focus of her COVID-19 work was ensuring equitable access and improving outcomes for historically marginalized populations. Before NCDHHS, Dr. Mallick worked closely with a range of healthcare stakeholders across the public and private sectors – including state Medicaid agencies, provider organizations, managed care organizations, and other payors. Her prior federal experience includes serving as a Senior Medical Advisor in the Office of the Administrator at CMS, Center for Medicare and Medicaid Services. She earned her A.B. with honors from Harvard College, her M.D. from Stanford University School of Medicine, and completed internal medicine residency at Massachusetts General Hospital and Harvard Medical School.
Henry Hoang Nguyen
MD Candidate, Student Representative
Henry Nguyen was born and raised in Abbeville, Louisiana, and is a proud graduate of Xavier University of Louisiana in New Orleans, Louisiana. Before becoming a Stanford medical student, Henry had the pleasure of co-founding organizations dedicated to increasing inclusivity in the fields of competitive athletics, the performing arts, and media production. He has found Stanford to be the perfect place to continue nurturing these organizations during medical school, and he has even picked up multiple new projects in the fields of biotechnology, medical education, and other forms of cutting-edge innovation. In his free time, Henry enjoys playing video games, binging K-Dramas, listening to podcasts, hanging out with friends, and napping.
Paula O’Connor
MD ’93
Paula O’Connor has served as the Senior Vice President of Clinical Development at Nurix Therapeutics since September 2022. Dr. O’Connor is trained as a hematologist-oncologist with more than 15 years of drug development expertise. Prior to joining Nurix, Dr. O’Connor held senior level positions in Clinical Development and Medical Affairs at Protagonist Therapeutics, Oncopeptides, Inc., Coherus Biosciences, Medivation, Onyx, and Genentech. Paula holds a B.A. in Psychology-Biology from Yale University, obtained her medical degree from Stanford University; did her medical residency at Massachusetts General Hospital, where she was the first African American Chief Resident in Internal Medicine. Dr. O’Connor completed her fellowships in Hematology, Oncology, and AIDS Oncology at the combined programs of the Massachusetts General, Brigham and Women’s, and Dana Farber Cancer Institute. Outside of work, Paula is a parent, a tennis fan, and the owner of 2 Burmese cats.
Johnny Powell
MD Candidate, Student Representative
Johnny G. Powell, originally from Greensboro, North Carolina, is an MD candidate and Knight-Hennessy Scholar at Stanford University School of Medicine. He graduated cum laude from Harvard University with a bachelor’s degree in chemistry and a minor in psychology. At Harvard, Johnny led youth mentorship programming in Boston and Japan, conducted research in the natural and social sciences, and shadowed hospital physicians in Spain. After graduating, he worked as an Associate Consultant at Bain & Company on healthcare and social impact projects. Passionate about health equity, Johnny also served as Research Coordinator for the All of Us Research Program, a national National Institutes of Health initiative to increase diversity in health care research, at the University of Chicago. In his free time, he enjoys weightlifting, watching sports, and volunteering with local community-based organizations.
Thomas Satterwhite
’00, MD ’04
Dr. Thomas Satterwhite obtained his bachelor’s degree (Human Biology with Honors) and Medical Degree at Stanford University. He remained at Stanford Hospital to complete his residency in Plastic & Reconstructive Surgery. His expertise in facial surgery was further refined with the completion of a craniofacial fellowship in Miami, FL under the tutelage of Dr. S. Anthony Wolfe. Dr. Satterwhite has presented nationally and internationally in plastic, reconstructive, craniofacial, and gender affirming surgery with more than 80 podium presentations over the years; and he has authored more than 50 peer-reviewed research articles and book chapters. He’s heavily engaged in numerous international and national organizations including the World Professional Association for Transgender Health and the American Society of Plastic Surgeons. He is a peer reviewer for multiple well-respected journals, and he is on the Editorial Board for the Journal of Plastic and Reconstructive Surgery. Dr. Satterwhite performs the full spectrum of gender affirmation surgical care in a private practice setting in San Francisco, CA since 2014 where he and his partner physicians at Align Surgical Associates provide comprehensive care in all aspects of gender affirming surgery for transmen, transwomen, non-binary, and gender diverse individuals. He is an Adjunct Clinical Assistant Professor in the Division of Plastic and Reconstructive Surgery at Stanford Medical Center.
Russell Stewart
’01, MS ’01, MD ’09
Dr. Stewart was an undergraduate student athlete at Stanford and received his BS and MS in Biological Sciences in 2001. He returned to Stanford in 2010 to complete his residency and fellowship in Diagnostic Radiology and joined the faculty as an Assistant Clinical Professor in 2015. He served as the Director of Body Imaging at the South Bay Cancer and Director of Quality Management for the Department of Radiology until 2018.
Dr. Stewart continues to practice clinically as a radiologist for Stanford and is helping lead early stage healthcare companies looking to utilize advanced technology and machine learning to empower physicians and improve patient care. He also continues to serve as an undergraduate pre-major advisor for incoming students at Stanford and maintains close ties with the Stanford Department of Athletics in helping recruit high school student athletes interested in careers in medicine.
Holly Tabor
PhD ’02
Holly Tabor received her PhD at Stanford in 2002 where she chose to focus her research on genetic epidemiology and embarked on what has been a career-long passion for interdisciplinarity, and bridging ideas, methodologies, and perspectives. After completing her PhD, she worked for four years as a Senior Scientist at the Stanford Human Genome Center, collaborating with the Division of Cardiovascular Medicine in the Department of Medicine and the Department of Genetics.
In 2005, she was one of the inaugural ethics postdoctoral fellows at the Stanford Center for Bioethics and also received training as a clinical ethicist, applying ethics scholarship and training to helping health care providers, patients and families navigate ethical challenges in hospitals. She has worked as Assistant Professor in the Division of Bioethics in the Department of Pediatrics at University of Washington and at the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Hospital.
In 2016, she returned to Stanford as an Associate Professor in the Department of Medicine and Associate Director for Clinical Ethics and Education at the Stanford Center for Biomedical Ethics. She teaches every medical student and PA student the “ethics thread” of required sessions and serves as Co-Course Director of the Responsible Conduct of Research course, taken by almost every graduate student and postdoctoral fellow in the School of Medicine.
Holly is a recipient of the Stanford School of Medicine Henry J. Kaiser Award for Excellence in Preclinical Teaching, the Stanford Faculty Women’s Allyship Award, and the Stanford Medicine Outstanding Community Engaged Faculty Award.
Nathan Trinklein
PhD ’03
Nathan received his Ph.D. from Stanford in 2003 with a focus on functional genomics. After graduating, he served as the Technical Director of the Stanford ENCODE pilot project. Nathan began his career as a biotech entrepreneur by co-founding SwitchGear Genomics based on technology developed at Stanford. After the acquisition of SwitchGear, he was part of starting a therapeutics immuno-oncology company called Teneobio where he currently serves as the Chief Technology Officer. Teneobio employs a sequence-based approach for antibody discovery that leverages next-generation sequencing and high-throughput functionally assays to develop fully-human multi-specific antibodies. Dr. Trinklein has authored over 30 peer-reviewed publications and is an inventor on over 15 patents.
Raymond Tsai
MD ’13
Dr. Raymond Tsai is a Family Medicine physician working in California’s Central Valley. He currently serves as Vice President, Advanced Primary Care for The Purchaser Business Group on Health, a nonprofit coalition of some of the largest employers and public purchasers in the nation committed to improving care quality, ensuring health equity, and reducing health care costs. In his current role, he collaborates with member employers and public purchasers, who collectively provide health coverage for 21 million Americans and their families, to ensure access to the best quality primary care and improve our overall healthcare system. Prior to this role, Dr. Tsai spent around 7 years providing executive medical leadership for a private company’s philanthropic mission to improve health outcomes for its agricultural workers and the communities in which they live in mostly rural and traditionally underserved areas in Central California. Raymond received his MD from Stanford in 2013, during which time he served his class for 4 years as Social Chair for Stanford Medical Student Association. He completed his residency in Family Medicine at UCLA and is also Board Certified in Clinical Informatics. Prior to medical school he obtained his B.A. in Music: Vocal Performance from UC San Diego, and MS in Health Policy and Management from Harvard T.H. Chan School of Public Health. Raymond has also worked at the World Health Organization, as well as in New Orleans establishing school-based health centers after Hurricanes Katrina and Rita. One of his favorite hobbies include carving pumpkins, which is a skill he cultivated as part of the anatomy lab competition at Stanford.
Steven Wang
PhD Candidate, Student Representative
Steven is a PhD student in the Stanford Cancer Biology program. Prior to Stanford, he earned a B.S. in Biological Sciences at Columbia University. Steven is an awardee of the Stanford Graduate Fellowship and NSF GRFP, and is conducting his thesis work in Dr. Howard Chang's lab. For his thesis, Steven aims to develop novel cancer vaccines for poorly immunogenic solid tumors, as well as elucidating the pathogenic mechanism of autoimmune diseases. After his PhD, Steven plans to explore opportunities to start or join an early-stage biotech company. Outside of work, Steven enjoys scuba diving, snowboarding, and basketball.
Monica Wiemer
’00, MD ’06, Resident ’09, Fellow ’15, MS ’15
Dr. Monica Eneriz Wiemer is a practicing pediatrician and the Vice President of People and Culture at the Palo Alto Foundation Medical Group. She leads her medical group’s strategies and initiatives on diversity, equity, and inclusion. She previously chaired the department of pediatrics at Good Samaritan Hospital in San Jose. Dr. Wiemer graduated from Stanford with a BA in Human Biology. She received her MD at Stanford and completed her pediatric residency at Lucile Packard Children’s Hospital.
As a Stanford fellow in academic general pediatrics, she studied the impact of language and literacy barriers on children’s health outcomes and completed a MS in health services research. As a Stanford medical student, Dr. Eneriz Wiemer served as president of the Stanford American Indigenous Medical Students, was an active member of the Latino Medical Student Association, and coordinated the Stanford University Minority Medical Alliance, a student organization dedicated to increasing diversity in medicine.
She lives in San Jose with her husband, Mike (BS ’00, MS ’01, PhD ’07) and their two children. She enjoys hiking and backpacking, gardening, and distance running.